Madhavi Puchalapalli

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models”.

Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models

PNAS Nexus(2022)10.1093/pnasnexus/pgac232

N/A

0.482DataRank · unranked

10 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors

Cell Death and Disease(2021)10.1038/s41419-021-03457-6

N/A

0DataRank · unranked

20 citations

Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Bin Hu, Madhavi Puchalapalli +6 more

Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0969

N/A

0DataRank · unranked

15 citations

Erica J. Peterson, Samantha J. Katner, Tia H. Turner, Mohammad A. Alzubi, J. Chuck Harrell +14 more

Exploitation of sulfated glycosaminoglycan status for precision medicine of platinums in triple-negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.05.442616

N/A

0DataRank · unranked

0 citations

Erica J. Peterson, Samantha J. Katner, Tia H. Turner, Mohammad A. Alzubi, J. Chuck Harrell +13 more

Genomic screening reveals UBA1 as a potent and druggable target in c-MYC-high TNBC models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.17.491908

N/A

0DataRank · unranked

0 citations

Tia H. Turner, Jinyang Cai, Konstantinos V. Floros, Ann K. Yu, Colin M. Coon +15 more

Data from MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

(2023)10.1158/0008-5472.c.6513141.v1

N/A

0DataRank · unranked

0 citations

Jinyang Cai, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Mayuri Shende +14 more

Data from Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer

(2023)10.1158/1535-7163.c.6543516

N/A

0DataRank · unranked

0 citations

Erica J. Peterson, Samantha J. Katner, Tia H. Turner, Mohammad A. Alzubi, J. Chuck Harrell +14 more

MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Cancer Research(2021)10.1158/0008-5472.can-20-1641

N/A

0DataRank · unranked

155 citations

Jinyang Cai, Sheeba Jacob, Richard Kurupi, Carter K. Fairchild, Mayuri Shende +14 more

The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway

Endocrinology(2024)10.1210/endocr/bqae039

N/A

0DataRank · unranked

5 citations

Senthil K. Radhakrishnan, J. Chuck Harrell, Madhavi Puchalapalli, Jennifer E. Koblinski, Charles V. Clevenger +1 more